275 related articles for article (PubMed ID: 24840212)
1. Evening and morning exhaled volatile compound patterns are different in obstructive sleep apnoea assessed with electronic nose.
Kunos L; Bikov A; Lazar Z; Korosi BZ; Benedek P; Losonczy G; Horvath I
Sleep Breath; 2015 Mar; 19(1):247-53. PubMed ID: 24840212
[TBL] [Abstract][Full Text] [Related]
2. An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea.
Dragonieri S; Porcelli F; Longobardi F; Carratù P; Aliani M; Ventura VA; Tutino M; Quaranta VN; Resta O; de Gennaro G
J Breath Res; 2015 Apr; 9(2):026005. PubMed ID: 25891965
[TBL] [Abstract][Full Text] [Related]
3. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
[TBL] [Abstract][Full Text] [Related]
4. Exhaled biomarker pattern is altered in children with obstructive sleep apnoea syndrome.
Benedek P; Lázár Z; Bikov A; Kunos L; Katona G; Horváth I
Int J Pediatr Otorhinolaryngol; 2013 Aug; 77(8):1244-7. PubMed ID: 23746417
[TBL] [Abstract][Full Text] [Related]
5. Influence of circadian rhythm on exhaled breath profiling by electronic nose.
Liotino V; Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Biol Regul Homeost Agents; 2018; 32(5):1261-1265. PubMed ID: 30334423
[TBL] [Abstract][Full Text] [Related]
6. Lack of heritability of exhaled volatile compound pattern: an electronic nose twin study.
Tarnoki DL; Bikov A; Tarnoki AD; Lazar Z; Szilagyi BK; Korosi BZ; Horvath T; Littvay L; Losonczy G; Horvath I
J Breath Res; 2014 Mar; 8(1):016001. PubMed ID: 24421262
[TBL] [Abstract][Full Text] [Related]
7. Exhaled Breath Analysis in Obstructive Sleep Apnea Syndrome: A Review of the Literature.
Finamore P; Scarlata S; Cardaci V; Incalzi RA
Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31461988
[No Abstract] [Full Text] [Related]
8. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer.
Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I
BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554
[TBL] [Abstract][Full Text] [Related]
9. Breathing Rhythm Variations during Wash-In Do Not Influence Exhaled Volatile Organic Compound Profile Analyzed by an Electronic Nose.
Dragonieri S; Quaranta VN; Carratù P; Ranieri T; Buonamico E; Carpagnano GE
Molecules; 2021 May; 26(9):. PubMed ID: 34064506
[TBL] [Abstract][Full Text] [Related]
10. Detection of obstructive sleep apnoea by an electronic nose.
Greulich T; Hattesohl A; Grabisch A; Koepke J; Schmid S; Noeske S; Nell C; Wencker M; Jörres RA; Vogelmeier CF; Köhler U; Koczulla AR
Eur Respir J; 2013 Jul; 42(1):145-55. PubMed ID: 23100503
[TBL] [Abstract][Full Text] [Related]
11. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report.
Waltman CG; Marcelissen TAT; van Roermund JGH
Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583
[TBL] [Abstract][Full Text] [Related]
12. Exhaled carbon monoxide levels in obstructive sleep apnoea.
Kis A; Meszaros M; Tarnoki DL; Tarnoki AD; Lazar Z; Horvath P; Kunos L; Bikov A
J Breath Res; 2019 Jun; 13(3):036012. PubMed ID: 31108481
[TBL] [Abstract][Full Text] [Related]
13. Editor's Highlight: Prospective Analyses of Volatile Organic Compounds in Obstructive Sleep Apnea Patients.
Aoki T; Nagaoka T; Kobayashi N; Kurahashi M; Tsuji C; Takiguchi H; Tomomatsu K; Oguma T; Kobayashi N; Magatani K; Takeda S; Asano K; Abe T
Toxicol Sci; 2017 Apr; 156(2):362-374. PubMed ID: 28003437
[TBL] [Abstract][Full Text] [Related]
14. Electronic Nose Technology in Respiratory Diseases.
Dragonieri S; Pennazza G; Carratu P; Resta O
Lung; 2017 Apr; 195(2):157-165. PubMed ID: 28238110
[TBL] [Abstract][Full Text] [Related]
15. Exhaled volatile organic compounds analysis by e-nose can detect idiopathic pulmonary fibrosis.
Dragonieri S; Scioscia G; Quaranta VN; Carratu P; Venuti MP; Falcone M; Carpagnano GE; Foschino Barbaro MP; Resta O; Lacedonia D
J Breath Res; 2020 Jul; 14(4):047101. PubMed ID: 32320958
[TBL] [Abstract][Full Text] [Related]
16. Obstructive sleep apnea patients can be identified by ion mobility spectrometry-derived smell prints of different biological materials.
Greulich T; Fischer H; Lubbe D; Nell C; Ingo Baumbach J; Koehler U; Boeselt T; Vogelmeier C; Koczulla AR
J Breath Res; 2018 Feb; 12(2):026006. PubMed ID: 29083318
[TBL] [Abstract][Full Text] [Related]
17. Screening of Obstructive Sleep Apnea Syndrome by Electronic-Nose Analysis of Volatile Organic Compounds.
Scarlata S; Pennazza G; Santonico M; Santangelo S; Rossi Bartoli I; Rivera C; Vernile C; De Vincentis A; Antonelli Incalzi R
Sci Rep; 2017 Sep; 7(1):11938. PubMed ID: 28931931
[TBL] [Abstract][Full Text] [Related]
18. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
19. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436
[TBL] [Abstract][Full Text] [Related]
20. Effects of CPAP therapy withdrawal on exhaled breath pattern in obstructive sleep apnoea.
Schwarz EI; Martinez-Lozano Sinues P; Bregy L; Gaisl T; Garcia Gomez D; Gaugg MT; Suter Y; Stebler N; Nussbaumer-Ochsner Y; Bloch KE; Stradling JR; Zenobi R; Kohler M
Thorax; 2016 Feb; 71(2):110-7. PubMed ID: 26671307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
